Molecular diagnostic tests
The tests identify hereditary predisposition to cancer.
Source: LinkedIn company description · Retrieved November 17, 2026

Cogentech is a benefit company providing post-genomics technology services to the scientific community and hospitals.
Its services for the scientific community are for research, while those for hospitals are for diagnostic purposes. Since 2025, its Integrated Genomic Unit laboratory in Catania has been authorized for diagnostic activity.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The tests identify hereditary predisposition to cancer.
Source: LinkedIn company description · Retrieved November 17, 2026
Facilities include DNA Sanger Sequencing and Quantitative PCR, both within CGT Lab, as well as Genomic Unit, Histopathology Unit, Biological Research, Proteomics & Metabolomics Facility, and Integrated Genomic Unit.
Source: LinkedIn company description · Retrieved November 17, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 29, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on November 17, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 18, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026, September 20, 2026, September 21, 2026, September 27, 2026, September 29, 2026 and November 6, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.